Skip to main navigation Skip to search Skip to main content

Baclofen successfully abolished prolonged central hyperthermia in a patient with basilar artery occlusion

  • Yung Sung Huang
  • , Ming Chang Hsiao
  • , Meng Lee
  • , Ying Chih Huang
  • , Jiann Der Lee*
  • *Corresponding author for this work
  • Chang Gung Memorial Hospital

Research output: Contribution to journal › Journal Article › peer-review

13 Scopus citations

Abstract

Hyperthermia, not uncommon in severe brainstem stroke, is frequently difficult to control and associated with a poor prognosis and high mortality. Successful treatment of central hyperthermia in patients with brainstem infarction by baclofen has not been described. Following basilar artery occlusion, a 68-year-old female developed prolonged hyperthermia. Her hyperthermia did not respond to any antipyretic treatments. A water-cooling blanket was utilized to control her hyperthermia; however, body temperatures fluctuated at a range of 35.5-40.0°C. After given baclofen 30 mg/day, her body temperatures returned to a normal range and remained stable. Hyperthermia following severe brainstem infarction without any sign of infection or inflammatory sources usually comes from a central origin and is likely associated with dysfunctions of the thermoregulatory system. Baclofen may be one of the treatment choices in patients with neurogenic central hyperthermia.

Original languageEnglish
Pages (from-to)118-122
Number of pages5
JournalActa Neurologica Taiwanica
Volume18
Issue number2
StatePublished - 06 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Baclofen
  • Critical care
  • Hyperthermia
  • Stroke

Fingerprint

Dive into the research topics of 'Baclofen successfully abolished prolonged central hyperthermia in a patient with basilar artery occlusion'. Together they form a unique fingerprint.

Cite this